Jobs / United States / Kymera Therapeutics INC

Kymera Therapeutics INC

Vice President, Pharmaceutical Development

Watertown, MA Posted 1 month ago

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Skills this job asks for

LeadershipComplianceSupply chain

Add your CV (free) to see which of these your CV is missing.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 4 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Kymera Therapeutics INC paid sponsored hires in similar roles1 certified filing for “Director, Late Stage Formulations Development” (Natural Sciences Managers) in MA: $230k–$230k, median $230k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 4 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Kymera Therapeutics INC paid sponsored hires in similar roles
1 certified filing for “Director, Late Stage Formulations Development” (Natural Sciences Managers) in MA: $230k–$230k, median $230k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit  www.kymeratx.com or follow us on  X (formerly Twitter)  or  LinkedIn . How we work: • PIONEER : We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines. • COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. • BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you’ll make an impact: • Define and lead the company’s pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines • Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs • Champion innovation in formulation sciences and enabling technologies to address complex drug delivery and bioavailability challenges • Drive development and implementation of phase-appropriate drug product development and manufacturing strategies • Lead a high-performing Pharmaceutical Development team, in internal activities and management of an external network of CROs, CDMOs, and strategic partners • Establish scalable processes, operational frameworks, and best practices to support portfolio growth • Provide strategic oversight of outsourced development and manufacturing activities, ensuring quality, timelines, and technical objectives are achieved • Lead CMC-related regulatory strategy for drug product development activities, regulatory submissions and health authority interactions • Ensure compliance with applicable GMP and regulatory requirements • Represent Pharmaceutical Development in due diligence activities, external collaborations, and interactions with other functions • Contribute to risk assessment, resource prioritization, and investment decisions as a member of the Technical Operations leadership team • Foster strong cross-functional partnerships across Research, Clinical, Regulatory, Quality, Supply Chain, and Program Management to enable efficient advancement of pipeline programs Skills and experience you’ll bring: • Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemical Engineering, or related discipline with 18+ years of relevant pharmaceutical industry experience • Demonstrated success leading pharmaceutical development strategy from discovery through clinical development, with experience supporting commercialization readiness • Strong understanding of preformulation, biopharmaceutics, formulation development, and oral solid dose drug product manufacturing for small molecules • Deep expertise in formulation approaches for poorly soluble compounds, including application of enabling technologies to improve bioavailability and product performance • Proven track record of advancing programs through IND and clinical development milestones and contributing to

Apply on employer site ↗